Hologic, Inc. (NASDAQ:HOLX) Upgrades/Downgrades Report


Hologic, Inc. (NASDAQ:HOLX) has a 1 Year Target Estimate of $43.33. The stock traded with the volume of 2.9 Million in the last trading session. Hologic, Inc. opened at $38.85 and closed by showing an increase of 0.78%. The Bid price in the last session was $38.69 x 100 and the Ask price was $41.50 x 100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Hologic, Inc. has the Market Capitalization of 10.84 Billion. The Stock has its 52-week High of $41.66 and 52-Week Low of $31.84 and it touched its 52-week high on Dec 2, 2015 and 52-Week Low on Feb 12, 2016.

Hologic, Inc. reported its last Earnings on Nov 02 AMC where the company reported Actual EPS of $0.52/Share whereas, the Analyst Estimated EPS was $0.5/share. The difference between Actual EPS and Estimated EPS was $0.02/share. This represented an Earnings Surprise of 4%. The company will report its next earnings on Jan 25 – Jan 30 (Est.).

Some analyst provided their insight on Growth Estimates; Hologic, Inc. has the Current Quarter Earnings Growth rate of 10.9%. The Next Quarter growth is expected to be 10.6%. In the past 5 years, the stock has earnings growth rate of 7.66% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 9.73% per annum.

15 number of analysts also provided their insight on Hologic, Inc., where the Average Price Target for the stock is $43.33. They also projected Low Price Target as $39 while High Price Target is set at $48.

A number of analysts rated the stock as well: 8 analysts believe that the stock is a STRONG BUY while 6 reported it as Buy.7 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Hologic, Inc. annual Divided is 0 while it’s Dividend Yield is 0%. The stock has its Price to Earnings (P/E) ratio of 33.69 and Forward Price to Earnings ratio of 16.52. The company has its Price to Sales (P/S) ratio of 3.83 where Price to Book (P/B) ratio of 5.05, Price to Cash Per share (P/C) of 19.78 and Price to Free Cash Flow (P/FCF) has a value of 15.75.

The company has its Return on Assets (ROA) of 4.5 Percent. Return on Equity (ROE) stands at 15.8% and Return on Investment (ROI) displays a value of 8.4%.

The stock is currently trading at Distance from 20-Day simple moving Average of 3.45% whereas, Distance from 50-Day Simple moving average is 2.28 Percent and Distance from 200-Day Simple Moving Average of 7.33 percent.

A look at performance overview of Hologic, Inc. depicts that Performance (Week) is 0.85 percent while Performance Month is 8.34%. Quarterly performance shows a value of 1.35% and Half Year Performance value stands at 12.46%. Yearly performance of the stock has the value of -3.4 percent. Hologic, Inc. has its YTD performance of 0.75 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 14 Nov 2016 where Officer Oberton Karleen Marie did a transaction type “Sell” in which 1211 shares were traded at a price of $36.55. Another insider trade includes Officer Oberton Karleen Marie who also initiated a transaction in which 1794 shares were traded on 13 Nov 2016 as “Buy”. On 13 Nov 2016 Officer Oberton Karleen Marie traded 583 shares as “Sell” at $36.45. Chief Financial Officer Mcmahon Robert W Sell 1161 shares on 6 Nov 2016 at the price of $38.68.

Upgrades/Downgrades Report:

The latest Upgrades/Downgrades was done by Research firm Barclays on 23-Sep-16 who Upgrade the stock from Equal Weight to Overweight. Other firms have also Upgraded/Downgraded the stock. On 28-Apr-16, Needham took an action “Downgrade” from Buy to Hold. On 28-Jan-16, the stock was Upgrade to Buy by Needham.